DeepMed Research

Universitaire Ziekenhuizen Leuven

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.uzleuven.be

Clinical Trials

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

Completed

Conditions: Multiple Myeloma
Hematologic Diseases

First Posted Date: 2016-09-29

Last Posted Date: 2021-05-04

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 200

Registration Number: NCT02918695

Locations: 🇧🇪
ZNA Antwerpen, Antwerpen, Belgium
🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇧🇪
GHdC Charlerloi, Charleroi, Belgium

and more 17 locations

The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2016-09-26

Last Posted Date: 2024-06-27

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 100

Registration Number: NCT02914717

Golimumab Dried Blood Spot Analysis

Phase 4

Conditions: Ulcerative Colitis

Interventions: Other: Cohort B
Other: Cohort A

First Posted Date: 2016-09-22

Last Posted Date: 2017-10-27

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 10

Registration Number: NCT02910375

Locations: 🇧🇪
UZ Leuven, Leuven, Belgium
🇧🇪
AZ Groeninge, Belgium, Kortrijk, Belgium

Flash Glucose Monitoring Study for Diabetes

Completed

Conditions: Diabetes

First Posted Date: 2016-09-13

Last Posted Date: 2020-10-20

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 2331

Registration Number: NCT02898714

Locations: 🇧🇪
UZ Leuven, Leuven, Belgium

Geriatric-CO-mAnagement for Cardiology Patients in the Hospital

Not Applicable

Completed

Conditions: Geriatric Assessment
Activities of Daily Living
Cardiovascular Diseases
Length of Stay
Health Services for the Aged
Delirium
Frail Elderly

Interventions: Other: Cardio-geriatric co-management

First Posted Date: 2016-09-07

Last Posted Date: 2020-02-13

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 454

Registration Number: NCT02890927

Locations: 🇧🇪
University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium

The Influence of Sweet Substrates on Hunger, Gastrointestinal Hormones and the Migrating Motor Complex

Not Applicable

Completed

Conditions: Healthy

Interventions: Dietary Supplement: 25g fructose
Dietary Supplement: 50g glucose
Dietary Supplement: 220mg acesulfame-K
Dietary Supplement: 250mL tap water

First Posted Date: 2016-09-07

Last Posted Date: 2016-09-07

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 12

Registration Number: NCT02891525

RCT to Evaluate Biocompatibility of Resin-based Dental Materials

Not Applicable

Recruiting

Conditions: Materials Testing

Interventions: Procedure: Dental restoration

First Posted Date: 2016-08-22

Last Posted Date: 2024-07-03

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 200

Registration Number: NCT02874625

Locations: 🇧🇪
BIOMAT, Department of Oral Health Sciences, Leuven, Belgium

Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials

Not Applicable

Recruiting

Conditions: Materials Testing

Interventions: Procedure: Dental restoration

First Posted Date: 2016-08-22

Last Posted Date: 2024-07-03

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 100

Registration Number: NCT02874599

Locations: 🇧🇪
BIOMAT, Department of Oral Health Sciences, Leuven, Belgium

Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease

Not Applicable

Active, not recruiting

Conditions: Alcohol Abuse
Liver Disease

Interventions: Procedure: Plasma and head hair collection

First Posted Date: 2016-08-19

Last Posted Date: 2024-07-10

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 140

Registration Number: NCT02873663

Locations: 🇧🇪
UZ Leuven, Leuven, Vlaams Brabant, Belgium

Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer

Phase 2

Conditions: Ovarian Epithelial Cancer

Interventions: Drug: carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly
Drug: Olaparib

First Posted Date: 2016-07-04

Last Posted Date: 2021-01-29

Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Target Recruit Count: 160

Registration Number: NCT02822157

Locations: 🇧🇪
UZLeuven, Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy